Abstract
Studies were undertaken to elucidate the primary pathogenetic mechanisms responsible for immunoglobulin (Ig) A immune complexes formation and glomerular deposition in vivo. Monomeric (mIgA) and polymeric IgA (pIgA) anti-dinitrophenyl (DNP) were purified from MOPC 315 myeloma. A DNP-conjugated Ficoll was used as an antigen. For simulation of natural conditions of in vivo immune complex formation, 131I-DNP-Ficoll and 125I-IgA were administered through the intravenous and intraperitoneal routes, respectively. The kinetics half-life (t1/2) of the antigen (2.9 hours) and either the pIgA (7.2 hours) or mIgA (6.3 hours) in the experimental groups was not significantly different from the control. Glomerular IgA immune deposits were detectable only in mice that received pIgA and DNP-Ficoll. Plasma samples analyzed by gradient polyacrylamide gel electrophoresis revealed formation of large- and intermediate-sized pIgA complexes in circulation prior to glomerular deposition. Although mIgA failed to interact with such complexes in the circulation, it did bind to the pIgA immune deposits in the glomerulus. These results indicate that glomerular IgA immune deposits evolve from the localization of preformed circulating pIgA complexes that eventuates an in situ mIgA-mediated complex formation.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- André C., Berthoux F. C., André F., Gillon J., Genin C., Sabatier J. C. Prevalence of IgA2 deposits in IgA nephropathies: a clue to their pathogenesis. N Engl J Med. 1980 Dec 4;303(23):1343–1346. doi: 10.1056/NEJM198012043032306. [DOI] [PubMed] [Google Scholar]
- Bayer E. A., Skutelsky E., Wilchek M. The avidin-biotin complex in affinity cytochemistry. Methods Enzymol. 1979;62:308–315. doi: 10.1016/0076-6879(79)62235-8. [DOI] [PubMed] [Google Scholar]
- Clarkson A. R., Woodroffe A. J., Aarons I., Hiki Y., Hale G. IgA nephropathy. Annu Rev Med. 1987;38:157–168. doi: 10.1146/annurev.me.38.020187.001105. [DOI] [PubMed] [Google Scholar]
- Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
- Conley M. E., Cooper M. D., Michael A. F. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980 Dec;66(6):1432–1436. doi: 10.1172/JCI109998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Couser W. G., Salant D. J. In situ immune complex formation and glomerular injury. Kidney Int. 1980 Jan;17(1):1–13. doi: 10.1038/ki.1980.1. [DOI] [PubMed] [Google Scholar]
- Delacroix D. L., Dive C., Rambaud J. C., Vaerman J. P. IgA subclasses in various secretions and in serum. Immunology. 1982 Oct;47(2):383–385. [PMC free article] [PubMed] [Google Scholar]
- Donini U., Casanova S., Zini N., Zucchelli P. The presence of J chain in mesangial immune deposits of IgA nephropathy. Proc Eur Dial Transplant Assoc. 1983;19:655–662. [PubMed] [Google Scholar]
- Egido J., Sancho J., Blasco R., Rivera F., Hernando L. Immunopathogenetic aspects of IgA nephropathy. Adv Nephrol Necker Hosp. 1983;12:103–137. [PubMed] [Google Scholar]
- Eisenberg R., Plotz P. Symmetry of binding sites of a mouse IgA myeloma protein (MOPC 315). Biochemistry. 1978 Oct 31;17(22):4801–4807. doi: 10.1021/bi00615a030. [DOI] [PubMed] [Google Scholar]
- HELMKAMP R. W., GOODLAND R. L., BALE W. F., SPAR I. L., MUTSCHLER L. E. High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res. 1960 Nov;20:1495–1500. [PubMed] [Google Scholar]
- Komatsu N., Nagura H., Watanabe K., Nomoto Y., Kobayashi K. Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy. Nephron. 1983;33(1):61–64. doi: 10.1159/000182907. [DOI] [PubMed] [Google Scholar]
- Lomax-Smith J. D., Zabrowarny L. A., Howarth G. S., Seymour A. E., Woodroffe A. J. The immunochemical characterization of mesangial IgA deposits. Am J Pathol. 1983 Dec;113(3):359–364. [PMC free article] [PubMed] [Google Scholar]
- Monteiro R. C., Halbwachs-Mecarelli L., Roque-Barreira M. C., Noel L. H., Berger J., Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 1985 Oct;28(4):666–671. doi: 10.1038/ki.1985.181. [DOI] [PubMed] [Google Scholar]
- Newkirk M. M., Klein M. H., Katz A., Fisher M. M., Underdown B. J. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease. J Immunol. 1983 Mar;130(3):1176–1181. [PubMed] [Google Scholar]
- Plotz P. H., Rifai A. Stable, soluble, model immune complexes made with a versatile multivalent affinity-labeling antigen. Biochemistry. 1982 Jan 19;21(2):301–308. doi: 10.1021/bi00531a016. [DOI] [PubMed] [Google Scholar]
- Rifai A., Mannik M. Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol. 1983 Apr;130(4):1826–1832. [PubMed] [Google Scholar]
- Rifai A., Mannik M. Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med. 1984 Jul 1;160(1):125–137. doi: 10.1084/jem.160.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rifai A., Millard K. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol. 1985 May;60(2):363–368. [PMC free article] [PubMed] [Google Scholar]
- Rifai A., Small P. A., Jr, Teague P. O., Ayoub E. M. Experimental IgA nephropathy. J Exp Med. 1979 Nov 1;150(5):1161–1173. doi: 10.1084/jem.150.5.1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomino Y., Sakai H., Miura M., Endoh M., Nomoto Y. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol. 1982 Aug;49(2):419–425. [PMC free article] [PubMed] [Google Scholar]
- Valentijn R. M., Radl J., Haaijman J. J., Vermeer B. J., Weening J. J., Kauffmann R. H., Daha M. R., van Es L. A. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int. 1984 Nov;26(5):760–766. doi: 10.1038/ki.1984.213. [DOI] [PubMed] [Google Scholar]